World's Best Scientists 2026 revealed!
Yasuhiko Tomino

Yasuhiko Tomino

D-Index & Metrics

Medicine

D-Index
84
Citations
45145
World Ranking
14831
National Ranking
453

Overview

Yasuhiko Tomino is affiliated with Juntendo University in Japan and has focused their research primarily in the field of medicine, with substantial contributions to nephrology. Their academic work encompasses 56 publications in medicine, including 17 specifically in nephrology and additional work in hematology, genetics, molecular biology, and pulmonary and respiratory medicine.

The scientist's research interests include key topics such as dialysis and renal disease management, renal diseases and glomerulopathies, coagulation and related biochemical pathways, gout and hyperuricemia, chronic kidney disease, diabetes, platelet disorders, and vitamin K research. These topics reflect a concentration on kidney-related diseases and treatments.

Yasuhiko Tomino's frequent coauthors, indicating collaborative research efforts, include Yusuke Suzuki, Reo Kanda, Isao Ohsawa, Daisuke Honda, and Atsuko Urita. These partnerships have likely contributed to a consistent output in specialized medical fields.

The scientist's papers have appeared in various academic journals, with frequent contributions to:

  • Clinical and Experimental Nephrology
  • Nihon Toseki Igakkai Zasshi
  • Therapeutic Apheresis and Dialysis
  • Intractable & Rare Diseases Research
  • Scientific Reports

Among notable recent publications are:

  • "Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study," 2022, Scientific Reports
  • "Effects of l-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis," 2020, Nutrients
  • "Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan)," 2020, Journal of Diabetes Investigation
  • "Novel coronavirus disease in patients with end-stage kidney disease," 2020, Therapeutic Apheresis and Dialysis
  • "Association of serum uric acid, morning home blood pressure and cardiovascular risk factors in a population with previous prehypertension: a cross-sectional study," 2020, BMJ Open

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Revised equations for estimated GFR from serum creatinine in Japan.

    Seiichi Matsuo;Enyu Imai;Masaru Horio;Yoshinari Yasuda

  • The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers

  • Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

    Hitoshi Suzuki;Run Fan;Zhixin Zhang;Rhubell Brown

  • Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling

    Katsuhiko Asanuma;Etsuko Yanagida-Asanuma;Christian Faul;Yasuhiko Tomino

  • mRNA Expression of Growth Factors in Glomeruli From Diabetic Rats

    Tsukasa Nakamura;Mitsumine Fukui;Isao Ebihara;Shiori Osada

  • IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1

    Hitoshi Suzuki;Zina Moldoveanu;Stacy Hall;Rhubell Brown

  • Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy

    Francois Berthoux;Francois Berthoux;Hitoshi Suzuki;Lise Thibaudin;Lise Thibaudin;Hiroyuki Yanagawa

  • The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

    Toshio Ogihara;Kenjiro Kikuchi;Toshiro Fujita;Jitsuo Higaki

  • The MEST score provides earlier risk prediction in lgA nephropathy

    Sean J. Barbour;Sean J. Barbour;Gabriela Espino-Hernandez;Heather N. Reich;Rosanna Coppo

  • Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial

    Kenjiro Kimura;Tatsuo Hosoya;Shunya Uchida;Masaaki Inaba

  • A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study

    Masashi Goto;Kenji Wakai;Takashi Kawamura;Masahiko Ando

  • Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.

    Hideo Shiiki;Takao Saito;Yoshiharu Nishitani;Tetsuya Mitarai

  • MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis

    Katsuhiko Asanuma;Isei Tanida;Isao Shirato;Takashi Ueno

  • A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study

    Kenji Wakai;Takashi Kawamura;Masayuki Endoh;Masayo Kojima

  • Podocyte Migration during Nephrotic Syndrome Requires a Coordinated Interplay between Cathepsin L and α3 Integrin

    Jochen Reiser;Jun Oh;Isao Shirato;Katsuhiko Asanuma

  • THE OXFORD IGA NEPHROPATHY CLINICOPATHOLOGICAL CLASSIFICATION IS VALID FOR CHILDREN AS WELL AS ADULTS

    Rosanna Coppo;Stéphan Troyanov;Roberta Camilla;Ronald J. Hogg

  • FcRn-mediated transcytosis of immunoglobulin G in human renal proximal tubular epithelial cells

    Noriyoshi Kobayashi;Yusuke Suzuki;Toshinao Tsuge;Ko Okumura

  • Toll-Like Receptor 9 Affects Severity of IgA Nephropathy

    Hitoshi Suzuki;Yusuke Suzuki;Ichiei Narita;Masashi Aizawa

Frequent Co-Authors

Jan Novak
Jan Novak University of Alabama at Birmingham
Bruce A. Julian
Bruce A. Julian University of Alabama at Birmingham
Seiichi Matsuo
Seiichi Matsuo Nagoya University
Ko Okumura
Ko Okumura Juntendo University
Hirofumi Makino
Hirofumi Makino Okayama University
Toshikazu Shirai
Toshikazu Shirai Juntendo University
Takashi Ueno
Takashi Ueno Juntendo University
Zina Moldoveanu
Zina Moldoveanu University of Alabama at Birmingham
Chisei Ra
Chisei Ra Juntendo University
Vivette D. D'Agati
Vivette D. D'Agati Columbia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean committing to medical school. There are several flexible options available for students seeking healthcare roles. For those interested in becoming a nurse, you might consider one of the easiest nursing schools to get into. These programs can help you start your healthcare journey with fewer barriers.

Another pathway is in medical administration. Earning a degree in healthcare administration online allows you to move into leadership roles within hospitals and clinics. For students focused on practical nursing, explore lpn to rn programs without teas test to advance your credentials quickly.

If you prefer non-clinical work, training at one of the top medical billing and coding online schools can prepare you for essential roles in healthcare documentation and administration. These diverse educational pathways offer opportunities to join the medical field from a variety of starting points.

Best Scientists Citing Yasuhiko Tomino

Trending Scientists

Recently Published Articles